Trial
NCT01237678
A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
ImmunoGen, Inc.
Collaborators
—
Condition
Small Cell Lung Cancer
Intervention
IMGN901
Why stopped
Study was stopped early due to lack of efficacy signal and safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-18